APA (7th ed.) Citation

Dhital, R., Kim, Y., Kim, D., Hernandez-Aguirre, I., Hedberg, J., Martin, A., & Cassady, K. A. Ruxolitinib and oHSV combination therapy increases CD4 T cell activity and germinal center B cell populations in murine sarcoma. Elsevier.

Chicago Style (17th ed.) Citation

Dhital, Ravi, Yeaseul Kim, Doyeon Kim, Ilse Hernandez-Aguirre, Jack Hedberg, Alexia Martin, and Kevin A. Cassady. Ruxolitinib and OHSV Combination Therapy Increases CD4 T cell Activity and Germinal Center B Cell Populations in Murine Sarcoma. Elsevier.

MLA (9th ed.) Citation

Dhital, Ravi, et al. Ruxolitinib and OHSV Combination Therapy Increases CD4 T cell Activity and Germinal Center B Cell Populations in Murine Sarcoma. Elsevier.